You’re listening to Spotrate Companies in Focus

Oncolytics Biotech
Symbol: NASDAQ:ONCY

Oncolytics Biotech has reported promising durable responses in treating second-line RAS-mutant colorectal cancer, marking a notable advancement in its immunotherapy pipeline. |

Powered by the Spotrate Terminal — delivering coverage of the global security markets.